Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tiens Biotech Group is a global healthcare enterprise that specializes in the development and commercialization of nutraceuticals, dietary supplements, and wellness products. Headquartered in Tianjin, China, the company operates as a key subsidiary of the Tiens Group conglomerate, utilizing a multi-level marketing (MLM) model for international distribution. Its product portfolio is heavily influenced by Traditional Chinese Medicine (TCM) and includes items such as nutrient high calcium powder, herbal teas, and antioxidant supplements. The company maintains large-scale manufacturing facilities and research centers focused on health-related biotechnology and nutritional science. While previously traded on the American Stock Exchange, Tiens Biotech Group transitioned to a private entity to better align with its parent company's long-term strategic goals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tiens Biotech Group.